Tobias Martin Hohl MD
Assistant Professor, Medicine, University of Washington School of Medicine
Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Hohl
Dr. Tobias Hohl is an infectious disease specialist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Weill Cornell Medicine and has been in practice 25 years. Dr. Hohl accepts several types of health insurance, listed below. He is one of 33 doctors at Memorial Sloan Kettering Cancer Center who specialize in Infectious Disease. He has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2003 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2003
Weill Cornell MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2002 - 2028
WA State Medical License 2008 - 2015
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Polystyrene microplastic-induced pathophysiology is driven by disruption of efferocytosis.Ana C Codo, Jesus E Romero-Pichardo, Zhaoquan Wang, Mariano A Aufiero, Tomi Lazarov
Immunity. 2026-02-24 - Antibiotic-induced microbiota disruption impairs neutrophil-mediated immunity to respiratoryinfection in mice.Mariano A Aufiero, Tobias M Hohl
Biorxiv. 2025-11-18 - An IFN/STAT1/CYBB axis defines protective plasmacytoid DC-neutrophil crosstalk in Aspergillus fumigatus-infected mice.Yahui Guo, Mariano A Aufiero, Kathleen Am Mills, Simon A Grassmann, Hyunu Kim
The Journal of Clinical Investigation. 2025-10-15
Journal Articles
- Response to Comment on “Sterilizing Immunity in the Lung Relies on Targeting Fungal Apoptosis-like Programmed Cell Death”Tobias Hohl, MD, Science Magazine
Press Mentions
Cancer Patients May Be at Greater Risk of Death from COVID-19October 4th, 2022- Dangerous Fungal Lung Infections Could Be Treated with CAR T-cellsSeptember 28th, 2022
- Antibiotics Induce Invasive Candidiasis in Mice and Humans, Immunotherapy Could HelpMay 16th, 2022
Grant Support
- Fungal Pathogenicity Determinants through the Lens of Immune-Targeted Cancer TherapiesDARTMOUTH COLLEGE2025–2030
- Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal nicheSLOAN-KETTERING INST CAN RESEARCH2024–2029
- INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
- 2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
- Antifungal Immunity and the Mechanism of Fungal Programmed Cell DeathSLOAN-KETTERING INST CAN RESEARCH2019–2024
Insurance Accepted
- BCBS Blue Card PPO
First Choice
Multiplan PHCS PPO
Multiplan PPO
Premera BCBS Heritage & Heritage Plus 1Providence Health System Personal Option
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
